Is Inflammasome a Potential Target of Prophylaxis in Rheumatic Heart Disease?
- PMID: 30571276
- PMCID: PMC6317860
- DOI: 10.1161/CIRCULATIONAHA.118.036771
Is Inflammasome a Potential Target of Prophylaxis in Rheumatic Heart Disease?
Keywords: Editorials; IL-1β; acute rheumatic fever; group A streptococcus; hydroxychloroquine; inflammasomes; rheumatic heart disease.
Figures

Comment on
-
Dysregulated IL-1β-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine.Circulation. 2018 Dec 4;138(23):2648-2661. doi: 10.1161/CIRCULATIONAHA.118.033891. Circulation. 2018. PMID: 30571257
References
-
- Karthikeyan G and Guilherme L. Acute rheumatic fever. Lancet. 2018;392:161–174. - PubMed
-
- Zuhlke LJ, Beaton A, Engel ME, Hugo-Hamman CT, Karthikeyan G, Katzenellenbogen JM, Ntusi N, Ralph AP, Saxena A, Smeesters PR, Watkins D, Zilla P and Carapetis J. Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations. Curr Treat Options Cardiovasc Med. 2017;19:15. - PMC - PubMed
-
- Kim MLM WJ; Minigo G; Keeble JL; Garnham AL; Pacini G; Smyth GK; Speed TP; Carapetis J; Wicks IP A dysregulated IL-1β -GM-CSF axis in acute rheumatic fever that is limited by hydroxychloroquine. Circulation. 2018. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources